A Risk Stratification Model for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) – Expert Commentary
Non-muscle-invasive bladder cancers (NMIBC), Bacillus Calmette-Guerin (BCG), instillations of adjuvant intravesical chemotherapy, adjuvant chemotherapy for the intermediate-risk NMIBC.